In a post on X (formerly Twitter), Neuralink described the trial as “an important first step towards restoring not only digital freedom but also physical freedom.” The study is named the CONVOY Study.
The announcement follows Neuralink’s recent statement that it plans to launch its first international clinical trial in Canada.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
